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In quiescent Balb/c 3T3 cells, competence factors such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and platelet-de- 
rived growth factor (PDGF) synergize with progression factors such as insulin to initiate DNA synthesis. In this study, 
we found that colchicine, a microtubule-disrupting agent, acted synergistically with TPA, but not with insulin, to induce 
the maximal stimulation of DNA synthesis. Colchicine also synergized with PDGF in the presence of epidermal growth 
factor to elicit nearly the optimal induction of DNA synthesis. Moreover, it acted synergistically with fibroblast growth 
factor, another competence factor. These results suggest that colchicine acts as a progression factor like insulin in quies- 
cent Balb/c 3T3 cells. 
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1. INTRODUCTION 
Previous reports have demonstrated that there 
are at least two distinct regulatory phases that con- 
trol the cell cycle traversal of density-arrested 
Balb/c 3T3 cells [l-3]. A group of growth factors 
classified as competence factors could induce a 
competent state, then the competent cells could 
enter the S phase by the addition of another group 
of growth factors, progression factors, such as in- 
sulin or insulin-like growth factor-l. For example, 
PDGF acts as a competence factor and synergizes 
with insulin in the presence of EGF to initiate 
DNA synthesis [4]. Another competence factor 
TPA can act synergistically with insulin to induce 
DNA synthesis in the absence of EGF [5,6]. 
Classification of growth factors could help our 
understanding about the pathway of mitogenic 
signal transduction. It has been shown that the 
competence factors cause the activation of protein 
kinase C and enhance the expression of proto- 
oncogenes c-myc and c-fos similarly [7,8]. The ex- 
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istence of the progression factor-induced mRNAs 
has also been reported [9]. Although much infor- 
mation has accumulated, the mechanisms of signal 
transduction are not fully understood. 
Microtubule integrity has been suggested to be 
involved in proliferative regulation based on the 
observations that microtubule depolymerizing 
agents such as colchicine acted synergistically with 
some growth factors to stimulate DNA synthesis in 
quiescent cells [lo- 171. However, since detailed in- 
vestigation with Balb/c 3T3 cell lines has not been 
carried out, whether colchicine acts like a com- 
petence factor or a progression factor has not been 
determined. Here, we present evidence that col- 
chicine acts as a progression factor in quiescent 
Balb/c 3T3 cells. Several lines of evidence suggest 
that colchicine exerts its effect by depolymerizing 
cytoplasmic microtubules. 
2. MATERIALS AND METHODS 
2.1. Materials 
Colchicine, colcemid, insulin and TPA were purchased from 
Sigma. EGF, bovine pituitary FGF and PDGF were purchased 
from Collaborative Research (Waltham, MA). Tax01 was the 
gift from Dr Mattew Suffness of the Natural Product Branch, 
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Division of Cancer Treatment, National Cancer Institute 
(USA). Fetal calf serum was purchased from Gibco. 
2.2. Cell culture 
Balb/c 3T3 cells were from Drs I. Yahara and S. Koyasu (The 
Tokyo Metropolitan Institute of Medical Science). Cells were 
plated at 1.5-2.0 x lo’ per 35 mm dishes in 2.5 ml of Dulbec- 
co’s modified Eagle’s (DME) medium supplemented with 10% 
fetal calf serum. They were kept at 37°C in an atmosphere con- 
taining 5% COZ. 3 days after seeding when the cells were nearly 
confluent, they were given 1 ml of fresh DME medium contain- 
ing 0.25% fetal calf serum and then allowed to become quies- 
cent in 2 days. 
2.3. Incorporation of PH]thymidine into DNA 
The quiescent Balb/c 3T3 cells in 35 mm dishes were in- 
cubated with anti-microtubule drugs (or related agents) and/or 
peptide growth factors for 40 h at 37°C in the presence of 
[3H]thymidine (1 &i/ml). The cells were then rinsed in cold 
phosphate-buffered saline twice and incubated in 10% 
trichloroacetic acid for 30 min at 0°C. The trichloroacetic acid- 
precipitable material was solubilized in 1 ml of 0.4 M NaOH at 
4°C. After neutralization, the radioactivity was counted in a 
liquid scintillation counter. 
2.4. Preparation of Iumicolchicine 
Colchicine dissolved in 95% ethanol was converted to 
lumicolchicine by ultraviolet irradiation as described [18]. 
3. RESULTS AND DISCUSSION 
Measurements of [3HJthymidine incorporation 
in quiescent Balb/c 3T3 cells stimulated by TPA 
and/or insulin have shown that TPA alone in- 
itiated DNA synthesis only slightly (fig.lA, l ), 
but in the presence of 1 PM insulin, TPA markedly 
induced DNA synthesis (fig.lA, 0), the level of 
which was comparable to that induced by 10% 
fetal calf serum. This result was consistent with the 
previous reports [5,6]. The addition of colchicine 
(1 pM) instead of insulin enhanced the stimulative 
effect of TPA on DNA synthesis (fig.lA, x); the 
thymidine incorporation reached the maximal evel 
that was induced by TPA plus insulin. In contrast, 
colchicine did not act synergistically with insulin 
(fig. 1B). Colchicine alone, like insulin alone, 
stimulated DNA synthesis only slightly (fig. 1). 
FGF, like TPA, synergized with insulin to in- 
duce DNA synthesis in quiescent Balb/c 3T3 cells 
(fig.2, 0), as was previously reported [3]. Col- 
chicine enhanced DNA synthesis stimulated by 
FGF as effectively as insulin did (fig.2, x). These 
data suggest hat colchicine acts as a progression 
factor, because colchicine synergized with a com- 
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Fig. 1. Effects of TPA, insulin and colchicine on the initiation 
of DNA synthesis in quiescent Balb/c 3T3 cells. Quiescent cells 
were treated with agents and [‘Hlthymidine for 40 h. 
Thymidine incorporation into trichloroacetic acid-insoluble 
material was measured as described in section 2.3. (A) Dose 
response curve for TPA in the presence of insulin or colchicine. 
Cells were exposed to indicated concentrations of TPA with no 
addition (0). 1 PM insulin (0) or 1 pM colchicine (x). (B) Dose 
response curve for insulin in the presence of TPA or colchicine. 
Cells were exposed to indicated concentrations of insulin with 
no addition (o), 30 ng/ml TPA (0) or 1 yM colchicine (x). 
Thymidine incorporation in cells stimulated by 10% fetal calf 
serum was 4.2-4.8 x 10’ cpm and this level was referred to as 
the optimal or maximal stimulation level in this paper. 
petence factor, TPA or FGF, and does not 
synergize with a progression factor, insulin. 
Colcemid, another microtubule-depolymerizing 
agent, also caused the enhancement of thymidine 
incorporation stimulated by TPA (table 1). Lumi- 
colchicine, a photoisomer of colchicine which does 
not depolymerize microtubules, did not enhance 
DNA synthesis stimulated by TPA (table 1). 
Taxol, a microtubule-stabilizing agent, inhibited 
the stimulation of DNA synthesis induced by col- 
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Fig.2. Dose response curve for FGF in stimulating DNA 
synthesis in the presence of insulin or colchicine. Quiescent 
Balb/c 3T3 cells were incubated for 40 h with various 
concentrations of FGF with no addition (o), 1 FM insulin (0) 
or 1 ,uM colchicine (x). [‘HlThymidine incorporation was 
measured. 
chicine (table 1). These data suggest hat colchicine 
exerts its stimulative effect on the initiation of 
DNA synthesis through microtubule depoly- 
merization. 
Because microtubule-depolymerizing agents in- 
hibit the formation of mitotic spindle, in order to 
investigate whether treatment with these agents in 
the presence of TPA induces the initiation of cell 
division as well as DNA synthesis, the 
microtubule-depolymerizing agents should be 
removed before M phase. To this end, colcemid 
was used since it can be removed much more easily 
Table 1 
Effects of anti-microtubule agents on the initiation of DNA 
synthesis in quiescent Balb/c 3T3 cells in the presence or 
absence of TPA (50 ng/ml) 
Treatment 13H]Thymidine incorporation 
(cpm x 10m4) 
- TPA + TPA 
No addition 
1 CM colchicine 
1 yM lumicolchicine 
1 pM colcemid 
1 FM colchicine + 
12 fiM taxol 
2.5 13.4 
8.6 42.5 
2.5 14.2 
9.3 45.9 
2.9 23.7 
Taxol, when present, was added to the cells 1 h before 
colchicine treatment. Thymidine incorporation was measured 
after 40 h incubation 
than colchicine by a thorough wash. After pulse 
treatment (6 h) with various concentrations of col- 
cemid in the presence of 100 ng/ml TPA, the cells 
were further incubated in the presence of TPA for 
40 h and then the cell number was counted. The 
result depicted in fig.3 shows that about 30% in- 
crease in the cell number was induced with 1 or 
3 ,uM colcemid treatment, while without colcemid 
treatment he increase induced by TPA alone was 
very small. 
It has been shown that in quiescent Balb/c 3T3 
cells, insulin synergizes with PDGF in the presence 
of EGF to stimulate the thymidine incorporation 
into DNA, and that the DNA synthesis induced by 
PDGF plus EGF plus insulin is nearly equal to that 
induced by 10% fetal calf serum [4]. Colchicine 
could replace insulin in this system (fig.4). PDGF 
plus colchicine, EGF plus colchicine, or PDGF 
plus EGF had only additive effect on the initiation 
of DNA synthesis, whereas PDGF plus EGF plus 
colchicine elicited the maximal, synergistic induc- 
tion of DNA synthesis, the level of which was 
equal to that induced by 10% fetal calf serum 
(fig.4). 
In this study, we have shown that colchicine 
synergized with competence factors such as TPA, 
FGF and PDGF plus EGF, but not with a progres- 
sion factor insulin, to initiate DNA synthesis in 
Colcemid OJM) 
Fig.3. Initiation of cell division by pulse treatment with 
colcemid in the presence of TPA. Quiescent cells were treated 
with indicated concentrations of colcemid for 6 h in the absence 
(0) or presence (0) of 100 ng/ml TPA. Colcemid was then 
removed by washing three times. After 72 h incubation in DME 
medium in the absence (0) or presence (0) of TPA, cell 
number was counted. 
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Fig.4. Effects of PDGF, EGF and colchicine on the initiation 
of DNA synthesis. Quiescent Balb/c 3T3 cells were incubated 
for 40 h with or without 10 ng/ml PDGF, 0.3 nM EGF and 
1 pM colchicine as indicated. Thymidine incorporation was 
measured. 
quiescent Balb/c 3T3 cells. Because this effect of 
colchicine was not mimicked by lumicolchicine and 
was inhibited by taxol pretreatment, it seems that 
colchicine exerts its effect by depolymerizing 
cytoplasmic microtubules. Thus, colchicine, i.e., 
microtubule depolymerization, acts as a progres- 
sion factor in Balb/c 3T3 cells. Since Bockus and 
Stiles reported that insulin caused transient 
microtubule depolymerization [191, it seems possi- 
ble that insulin initiates DNA synthesis by 
depolymerizing cytoplasmic microtubules. It is of 
interest to examine whether insulin and colchicine 
commonly elicit certain other cellular responses 
essential for the induction of DNA synthesis. Such 
examination could help our understanding about 
signal transduction mechanisms of progression 
factors. 
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